EMA to deal with industry concerns over new organizational structures
This article was originally published in SRA
Executive Summary
Changes to regulatory procedures can be unsettling at the best of times, and the past couple of years have brought the drug industry and regulators in Europe more than their fair share of new structures, processes and obligations.